Raymond James Financial Services Advisors’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-8
Closed -$74K 2522
2017
Q4
$74K Buy
+8
New +$74K ﹤0.01% 2393